SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Bob Trocchi who wrote (3138)11/8/2000 10:14:27 AM
From: Eric Fader  Read Replies (2) | Respond to of 5582
 
Bob - I'm surprised at the lack of demand. I guess that indicates that the advertising agency has some more work to do before Zicam can achieve "household name" status as I've predicted <g>. Would you consider popping into a pharmacy the next time you drive by one in a neighboring town? I'm just curious whether this is partly a CVS phenomenon, because I seem to remember someone in another area of the country mentioning that his local CVS didn't carry Zicam, or perhaps a local distributor issue. Thanks - Eric



To: Bob Trocchi who wrote (3138)11/8/2000 10:45:10 PM
From: Bo Didley  Read Replies (1) | Respond to of 5582
 
GUMM is on the radar for a Short Squeeze

High profile shorts are attacking this stock. When that happens there are hedgefunds, stock traders, swing traders,
and investors who watch closely for the short squeeze.

GUMM is a low float company and has been attacked by the shorts and at Silicon for many years. Last year, Bill Wexler a formidable short watch his short move against him from the $12 1/2 area all the way up to $35. He gave up shorting GUMM. That's what happens to shorts who short low and cover high. Some shorts lose their staying power and find better stocks to short. GUMM longs have been through tougher short and distort hype from criminals and liars and we didn't budge then and we're not budging now.

Watch for the short squeeze.